By BOPA Research Committee on 18th September 2024

Survey Participation Opportunity: Calling All Community Pharmacy Team Members

Dear members, The research subcommittee would like to share with you a message from Jackie Lewis, Pharmacy Director at Lewis Pharmacy. I am excited to launch a new international survey…

Read article
By BOPA Research Committee on 18th September 2024

131 abstracts have been accepted for the BOPA Conference in October

The BOPA Research Committee are delighted to announce that 131 abstracts have been accepted for the BOPA Conference in October and these will be subsequently published in the Journal of…

Read article
By BOPA committee on 18th September 2024

CRUK Publication update- National SACT Multiple Myeloma regimen specific consent forms

Dear All, I am delighted to inform you that the first phase of Multiple Myeloma regimen specific SACT consent forms are available for use on the CRUK website. All forms…

Read article
By BOPA Executive Committee on 17th September 2024

Introduction to Immune Checkpoint Inhibitors eLearning is LIVE for All Free and Paid BOPA Members

The winner of the #BOPA23 Oral Plenary Presentation Prize, Eleanor Meerstadt (UCLH) has collaborated with, Dr Pinkie Chambers, Dr Heather Shaw and EL Learning Design with funding from an independent medical…

Read article
By BOPA Executive Committee on 17th September 2024

RPS announces proposal to become a Royal College – BOPA and the UK PPL Board

BOPA are an ex-officio member of the UK PPL Board.  Please see the boards statement below on the RPS announcement of a proposal to become a Royal College: UK Pharmacy…

Read article
By BOPA Committee on 11th September 2024

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course, 11 November 2024, Royal College of Physicians, London

This joint British Cardiovascular Society, British Cardio-Oncology Society and University College London Hospitals Cancer Academy course provides an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology.…

Read article
By BOPA Research Committee on 11th September 2024

Treatment delays and new evidence

Dear BOPA members We are delighted to share two studies that you may be interested in for your practices.  The studies outline the impact of treatment delays (i.e. Delays in…

Read article
By BOPA Research Committee on 9th September 2024

BOPA member publication on the impact of inter-cycle treatment delays on mortality in early-stage breast cancer

We would like to share a recent BOPA member publication Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective…

Read article
By BOPA Research Committee on 9th September 2024

My Research Webinar: Understanding global participation in gynae-oncology RCTs: a systematic review approach

Wednesday 25th September 2024 13:00 GMT   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article
By BOPA Committee on 2nd September 2024

CRUK Consent Forms – Bladder cancer immunotherapy regimens

Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website. A new form for Nivolumab has been added. Revalidation of the remaining regimen specific consent…

Read article
By BOPA Education and Training Subcommittee on 28th August 2024

Are you a pharmacist experienced in managing chemotherapy induced nausea and vomiting?

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist…

Read article
By BOPA Committee on 28th August 2024

BOPA Podcast – Let’s Talk About DLBCL

The next episode of Let’s Talk About SACT is Let’s talk about Diffuse Large B Cell Lymphoma (DLBCL). In this episode we are joined by Chris Salmen. We discuss what…

Read article